Substituted pyridinone-pyridinyl compounds
US9365546B2 · kind B2 · utility
4Cited by
4References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2014 |
| Grant date | Jun 14, 2016 |
| Priority date | — |
| Expiry date | Jan 7, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides pyridinone-pyridinyl compounds useful in the treatment of p38 kinase mediated diseases, such as lymphoma and auto-inflammatory disease, having the structure of Formula (I):wherein R1, R2, R3, R4, R5, X and Y are as defined in the detailed description; pharmaceutical compositions comprising at least one of the compounds; and methods for treating p38 kinase mediated diseases using the compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.